Chunhua Lu Selected Research

Cu2ZnSnS4

3/2021

Rational design of a prodrug to inhibit self-inflammation for cancer treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunhua Lu Research Topics

Disease

82	Neoplasms (Cancer) 06/2024 - 10/2002
30	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 10/2006
17	Carcinoma (Carcinomatosis) 01/2021 - 08/2006
9	Breast Neoplasms (Breast Cancer) 01/2015 - 10/2002
8	Neoplasm Metastasis (Metastasis) 12/2023 - 02/2010
3	Inflammation (Inflammations) 12/2023 - 03/2021
3	Lung Neoplasms (Lung Cancer) 12/2023 - 04/2007
3	Carcinogenesis 02/2023 - 12/2003
3	Hypoxia (Hypoxemia) 05/2022 - 10/2014
3	Prediabetic State (Prediabetes) 02/2022 - 01/2022
3	Prostatic Neoplasms (Prostate Cancer) 08/2015 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 01/2017
2	Adenocarcinoma 05/2018 - 12/2010
2	Diabetes Mellitus 09/2012 - 06/2011
2	Necrosis 10/2007 - 10/2006
1	Triple Negative Breast Neoplasms 12/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2023
1	Leukemia 10/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Dyskinesias (Dyskinesia) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Memory Disorders (Memory Loss) 01/2023

Drug/Important Bio-Agent (IBA)

13	Small Interfering RNA (siRNA)IBA 04/2023 - 12/2006
11	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 10/2006
11	Proteins (Proteins, Gene)FDA Link 02/2023 - 09/2005
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 08/2006
9	Docetaxel (Taxotere)FDA Link 01/2014 - 10/2006
8	Paclitaxel (Taxol)FDA LinkGeneric 04/2024 - 11/2006
8	MicroRNAs (MicroRNA)IBA 04/2023 - 01/2009
6	Bevacizumab (Avastin)FDA Link 01/2023 - 12/2007
5	LigandsIBA 04/2023 - 02/2007
5	Therapeutic UsesIBA 01/2023 - 01/2021
5	PlatinumIBA 01/2021 - 11/2006
5	geldanamycinIBA 06/2015 - 10/2014
5	taxaneIBA 10/2013 - 11/2006
4	Messenger RNA (mRNA)IBA 04/2024 - 11/2006
4	Biomarkers (Surrogate Marker)IBA 04/2023 - 10/2006
4	Oncogene Proteins (Oncogene Protein)IBA 02/2023 - 11/2006
4	Peptides (Polypeptides)IBA 01/2023 - 10/2002
4	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 06/2011
4	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2022 - 04/2007
4	Cisplatin (Platino)FDA LinkGeneric 05/2013 - 01/2009
4	1,2-oleoylphosphatidylcholine (DOPC)IBA 04/2013 - 12/2006
4	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 07/2006 - 10/2002
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2023 - 02/2023
3	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 01/2022
3	Interleukin-8 (Interleukin 8)IBA 01/2018 - 11/2010
3	Transcription Factors (Transcription Factor)IBA 06/2015 - 10/2002
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014 - 10/2002
3	Taxoids (Taxanes)IBA 01/2014 - 01/2007
3	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2013 - 11/2007
3	CatecholaminesIBA 05/2013 - 08/2006
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2010 - 11/2006
3	Monoclonal AntibodiesIBA 09/2009 - 10/2006
3	Phosphotransferases (Kinase)IBA 01/2009 - 10/2002
3	AEE 788 (AEE788)IBA 07/2007 - 10/2006
2	MetalsIBA 06/2024 - 01/2023
2	Nucleic AcidsIBA 04/2024 - 12/2022
2	Photosensitizing Agents (Photosensitizers)IBA 11/2023 - 12/2022
2	Tyrosine Kinase InhibitorsIBA 10/2023 - 12/2003
2	A-Form DNA (A-DNA)IBA 04/2023 - 10/2018
2	EnzymesIBA 01/2023 - 05/2020
2	Glutathione (Reduced Glutathione)IBA 05/2022 - 01/2022
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2022
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 10/2018
2	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2021
2	CytokinesIBA 03/2021 - 05/2010
2	Type III Secretion SystemsIBA 01/2020 - 01/2018
2	AndrogensIBA 08/2015 - 01/2015
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2015 - 06/2015
2	Dasatinib (BMS 354825)FDA Link 04/2014 - 08/2011
2	Dopamine Receptors (Dopamine Receptor)IBA 05/2013 - 06/2011
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 05/2013 - 08/2006
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 09/2012 - 06/2011
2	Adrenergic Agents (Adrenergic Drugs)IBA 06/2011 - 08/2006
2	Estrogen ReceptorsIBA 12/2010 - 12/2003
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2010 - 11/2006
2	afliberceptIBA 12/2008 - 04/2008
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2007 - 01/2007
2	Cell-Free Nucleic AcidsIBA 01/2007 - 10/2006
2	ErbB Receptors (EGF Receptor)IBA 01/2007 - 12/2003
1	TeaIBA 06/2024
1	Catechin (Z 7300)IBA 06/2024
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2024
1	Antisense DNAIBA 04/2024
1	ResveratrolIBA 12/2023
1	lapacholIBA 12/2023
1	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2023
1	Ligases (Synthetase)IBA 10/2023
1	UbiquitinIBA 10/2023
1	Epithelial Cell Adhesion MoleculeIBA 04/2023
1	Dihydroxyphenylalanine (Dopa)IBA 01/2023
1	Tannic Acid FDA Link 01/2023
1	Catalytic DNA (Deoxyribozyme)IBA 01/2023
1	AcidsIBA 01/2023

Therapy/Procedure

42	Therapeutics 06/2024 - 10/2006
14	Drug Therapy (Chemotherapy) 04/2024 - 10/2006
4	Radiotherapy 01/2019 - 02/2015
3	Precision Medicine 04/2023 - 01/2019
3	Immunotherapy 01/2023 - 01/2021